Evidence map›Paper›PMID 33335152›Full record

ArticleScientific reports2020

Fabrication and characterization of mechanically competent 3D printed polycaprolactone-reduced graphene oxide scaffolds.

Amir Seyedsalehi, Leila Daneshmandi, Mohammed Barajaa, John Riordan, Cato T Laurencin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. A Tissue Engineering's Guide to Biomimicry.Macromolecular bioscience · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Development of porcine skeletal muscle extracellular matrix-derived hydrogels with improved properties and low immunogenicity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amir SeyedsalehiConnecticut Convergence Institute for Translation in Regenerative Engineering, UConn Health, 293 Farmington Avenue, Farmington, CT, 06030, USA.ORCID 0000-0002-2296-5247
Leila DaneshmandiConnecticut Convergence Institute for Translation in Regenerative Engineering, UConn Health, 293 Farmington Avenue, Farmington, CT, 06030, USA.ORCID 0000-0003-0505-7391
Mohammed BarajaaConnecticut Convergence Institute for Translation in Regenerative Engineering, UConn Health, 293 Farmington Avenue, Farmington, CT, 06030, USA.ORCID 0000-0002-1987-3739
John RiordanConnecticut Convergence Institute for Translation in Regenerative Engineering, UConn Health, 293 Farmington Avenue, Farmington, CT, 06030, USA.ORCID 0000-0002-0957-652X
Cato T LaurencinConnecticut Convergence Institute for Translation in Regenerative Engineering, UConn Health, 293 Farmington Avenue, Farmington, CT, 06030, USA. Laurencin@uchc.edu.ORCID 0000-0001-6765-3047
University of Connecticut · US

Funding

Regenerative Engineering of Complex Musculoskeletal Tissues and JointsDP1AR068147 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2014 to 2018
$4.1M
NIAMS NIH HHS DP1 AR068147NIH HHS DP1-AR-068147
6 · The paper itself

Abstract

The ability to produce constructs with a high control over the bulk geometry and internal architecture has situated 3D printing as an attractive fabrication technique for scaffolds. Various designs and inks are actively investigated to prepare scaffolds for different tissues. In this work, we prepared 3D printed composite scaffolds comprising polycaprolactone (PCL) and various amounts of reduced graphene oxide (rGO) at 0.5, 1, and 3 wt.%. We employed a two-step fabrication process to ensure an even mixture and distribution of the rGO sheets within the PCL matrix. The inks were prepared by creating composite PCL-rGO films through solvent evaporation casting that were subsequently fed into the 3D printer for extrusion. The resultant scaffolds were seamlessly integrated, and 3D printed with high fidelity and consistency across all groups. This, together with the homogeneous dispersion of the rGO sheets within the polymer matrix, significantly improved the compressive strength and stiffness by 185% and 150%, respectively, at 0.5 wt.% rGO inclusion. The in vitro response of the scaffolds was assessed using human adipose-derived stem cells. All scaffolds were cytocompatible and supported cell growth and viability. These mechanically reinforced and biologically compatible 3D printed PCL-rGO scaffolds are a promising platform for regenerative engineering applications.

Indexed as

Printing, Three-DimensionalTissue EngineeringCell AdhesionCell Culture TechniquesCell SurvivalGraphiteHumansHydrophobic and Hydrophilic InteractionsMaterials TestingMechanical PhenomenaPolyestersPorosityThermogravimetryTissue Scaffoldsgraphene oxideGraphitepolycaprolactonePolyesters

Identifiers

PMID33335152
PMCPMC7747749
OpenAlexW3111704445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.